An experimental vaccine could offer fresh hope to women diagnosed with an aggressive and hard-to-treat form of breas ...

A groundbreaking treatment has been announced for women with an extremely aggressive form of breast cancer. Siteman Cancer ...

Dr. Beata Halassy, a 49-year-old virologist, self-treated her recurrent breast cancer with OVT, a method that leverages ...

Researchers say the results mark the first time a vaccine - known as a neoantigen DNA vaccine - has shown such positive ...

First patient dosed in randomized, Phase 2 study in presurgical triple negative breast cancer SHELTON, Conn., Nov. 13, 20 ...

Breast cancer patients have been given fresh hope after a new vaccine showed “promise” in treating an aggressive form of the ...

A McGregor woman, who survived a tough battle with breast cancer, is sharing her journey to emphasize the importance of ...

BioNTech said that BNT327 has the "potential to replace current checkpoint inhibitor standard of care treatments for solid ...

Plan to announce initial clinical data for XMT-1660 at a company event by the end of 2024 Dose escalation advancing in Phase 1 clinical trial of XMT-2056 Conference call today at 8:00 a.m. ET CAMBRIDG ...

DALLAS, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Instil Bio, Inc. ("Instil”) (Nasdaq: TIL), a clinical-stage biopharmaceutical ...

Biotheus’ antibody drug targets PD-L1 and VEGF, a design that’s high on drugmakers’ radars after the success of Summit ...